Securities and Exchange Commission

Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities

The amount of other than temporary impairment losses on investments in debt and equity securities categorized as Available-for-sale which have been recognized in earnings during the period. Such impairment losses consist of other than temporary impairments (OTTI) on equity securities, credit losses on investments in debt securities, and when the entity intends to sell an impaired debt security or it is more likely than not that the entity will be required to sell the impaired debt security before recovery of its amortized cost basis.

Compare To Other Companies

Annual (USD)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
$148,000,000.00	2018-03-01	10-K	2017	FY	2015-01-01	2015-12-31	CY2015
$0.00	2019-02-26	10-K	2018	FY	2016-01-01	2016-12-31	CY2016
$0.00	2019-02-26	10-K	2018	FY	2017-01-01	2017-12-31	CY2017
$0.00	2019-02-26	10-K	2018	FY	2018-01-01	2018-12-31	CY2018

Quarterly (USD)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
$15,997,000.00	2013-05-09	10-Q	2013	Q1	2011-12-31	2012-03-31	CY2012Q1
$6,967,000.00	2013-08-06	10-Q	2013	Q2	2012-04-01	2012-06-30	CY2012Q2
$2,081,000.00	2013-11-07	10-Q	2013	Q3	2012-07-01	2012-09-30	CY2012Q3
$9,715,000.00	2013-05-09	10-Q	2013	Q1	2012-12-30	2013-03-31	CY2013Q1
$8,539,000.00	2014-08-07	10-Q	2014	Q2	2013-04-01	2013-06-30	CY2013Q2
$9,070,000.00	2014-11-06	10-Q	2014	Q3	2013-07-01	2013-09-30	CY2013Q3
$41,647,000.00	2015-05-07	10-Q	2015	Q1	2014-01-01	2014-03-31	CY2014Q1
$1,238,000.00	2015-08-06	10-Q	2015	Q2	2014-04-01	2014-06-30	CY2014Q2
$20,063,000.00	2015-11-06	10-Q	2015	Q3	2014-07-01	2014-09-30	CY2014Q3
$1,198,000.00	2016-05-09	10-Q	2016	Q1	2015-01-01	2015-03-31	CY2015Q1
$146,315,000.00	2016-08-05	10-Q	2016	Q2	2015-04-01	2015-06-30	CY2015Q2
$59,000.00	2016-11-07	10-Q	2016	Q3	2015-07-01	2015-09-30	CY2015Q3
$0.00	2017-05-08	10-Q	2017	Q1	2016-01-01	2016-03-31	CY2016Q1
$5,000.00	2016-08-05	10-Q	2016	Q2	2016-04-01	2016-06-30	CY2016Q2
$2,000.00	2016-11-07	10-Q	2016	Q3	2016-07-01	2016-09-30	CY2016Q3
$0.00	2017-05-08	10-Q	2017	Q1	2017-01-01	2017-03-31	CY2017Q1

All Reported Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities (USD)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
$15,997,000.00	2013-05-09	10-Q	2013	Q1	2011-12-31	2012-03-31	CY2012Q1
$22,964,000.00	2013-08-06	10-Q	2013	Q2	2012-01-01	2012-06-30
$6,967,000.00	2013-08-06	10-Q	2013	Q2	2012-04-01	2012-06-30	CY2012Q2
$25,045,000.00	2013-11-07	10-Q	2013	Q3	2012-01-01	2012-09-30
$2,081,000.00	2013-11-07	10-Q	2013	Q3	2012-07-01	2012-09-30	CY2012Q3
$9,715,000.00	2013-05-09	10-Q	2013	Q1	2012-12-30	2013-03-31	CY2013Q1
$9,715,000.00	2014-05-08	10-Q	2014	Q1	2013-01-01	2013-03-31
$18,254,000.00	2014-08-07	10-Q	2014	Q2	2013-01-01	2013-06-30
$18,254,000.00	2013-08-06	10-Q	2013	Q2	2013-01-01	2013-06-30
$8,539,000.00	2014-08-07	10-Q	2014	Q2	2013-04-01	2013-06-30	CY2013Q2
$8,539,000.00	2013-08-06	10-Q	2013	Q2	2013-04-01	2013-06-30
$27,324,000.00	2014-11-06	10-Q	2014	Q3	2013-01-01	2013-09-30
$27,324,000.00	2013-11-07	10-Q	2013	Q3	2013-01-01	2013-09-30
$9,070,000.00	2014-11-06	10-Q	2014	Q3	2013-07-01	2013-09-30	CY2013Q3
$9,070,000.00	2013-11-07	10-Q	2013	Q3	2013-07-01	2013-09-30
$41,647,000.00	2015-05-07	10-Q	2015	Q1	2014-01-01	2014-03-31	CY2014Q1
$41,647,000.00	2014-05-08	10-Q	2014	Q1	2014-01-01	2014-03-31
$42,885,000.00	2015-08-06	10-Q	2015	Q2	2014-01-01	2014-06-30
$41,653,000.00	2014-08-07	10-Q	2014	Q2	2014-01-01	2014-06-30
$1,238,000.00	2015-08-06	10-Q	2015	Q2	2014-04-01	2014-06-30	CY2014Q2
$6,000.00	2014-08-07	10-Q	2014	Q2	2014-04-01	2014-06-30
$62,948,000.00	2015-11-06	10-Q	2015	Q3	2014-01-01	2014-09-30
$62,948,000.00	2014-11-06	10-Q	2014	Q3	2014-01-01	2014-09-30
$20,063,000.00	2015-11-06	10-Q	2015	Q3	2014-07-01	2014-09-30	CY2014Q3
$20,063,000.00	2014-11-06	10-Q	2014	Q3	2014-07-01	2014-09-30
$1,198,000.00	2016-05-09	10-Q	2016	Q1	2015-01-01	2015-03-31	CY2015Q1
$1,198,000.00	2015-05-07	10-Q	2015	Q1	2015-01-01	2015-03-31
$147,513,000.00	2016-08-05	10-Q	2016	Q2	2015-01-01	2015-06-30
$147,513,000.00	2015-08-06	10-Q	2015	Q2	2015-01-01	2015-06-30
$146,315,000.00	2016-08-05	10-Q	2016	Q2	2015-04-01	2015-06-30	CY2015Q2
$146,315,000.00	2015-08-06	10-Q	2015	Q2	2015-04-01	2015-06-30
$147,572,000.00	2016-11-07	10-Q	2016	Q3	2015-01-01	2015-09-30
$147,572,000.00	2015-11-06	10-Q	2015	Q3	2015-01-01	2015-09-30
$59,000.00	2016-11-07	10-Q	2016	Q3	2015-07-01	2015-09-30	CY2015Q3
$59,000.00	2015-11-06	10-Q	2015	Q3	2015-07-01	2015-09-30
$148,000,000.00	2018-03-01	10-K	2017	FY	2015-01-01	2015-12-31	CY2015
$0.00	2017-05-08	10-Q	2017	Q1	2016-01-01	2016-03-31	CY2016Q1
$2,000.00	2016-05-09	10-Q	2016	Q1	2016-01-01	2016-03-31
$7,000.00	2016-08-05	10-Q	2016	Q2	2016-01-01	2016-06-30
$5,000.00	2016-08-05	10-Q	2016	Q2	2016-04-01	2016-06-30	CY2016Q2
$9,000.00	2016-11-07	10-Q	2016	Q3	2016-01-01	2016-09-30
$2,000.00	2016-11-07	10-Q	2016	Q3	2016-07-01	2016-09-30	CY2016Q3
$0.00	2019-02-26	10-K	2018	FY	2016-01-01	2016-12-31	CY2016
$0.00	2018-03-01	10-K	2017	FY	2016-01-01	2016-12-31
$0.00	2017-05-08	10-Q	2017	Q1	2017-01-01	2017-03-31	CY2017Q1
$0.00	2019-02-26	10-K	2018	FY	2017-01-01	2017-12-31	CY2017
$0.00	2018-03-01	10-K	2017	FY	2017-01-01	2017-12-31
$0.00	2019-02-26	10-K	2018	FY	2018-01-01	2018-12-31	CY2018